Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
John J. Arcaroli(University of Colorado Cancer Center), Wells A. Messersmith(University of Colorado Denver)
Cited by 37
Related Papers
KRAS Mutation
|Journal of Molecular Diagnostics|2009|110
Potent antitumor activity of cabozantinib, a c‐<scp>MET</scp> and <scp>VEGFR</scp>2 inhibitor, in a colorectal cancer patient‐derived tumor explant model
|International Journal of Cancer|2014|61